Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01591876
Other study ID # 12/WS/0129
Secondary ID
Status Recruiting
Phase Phase 2
First received April 30, 2012
Last updated February 28, 2013
Start date November 2012
Est. completion date February 2014

Study information

Verified date February 2013
Source Queen Margaret University
Contact Sean Prescott, MSc
Phone +447980338486
Email sprescott@qmu.ac.uk
Is FDA regulated No
Health authority United Kingdom: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate whether a three month intra-dialytic exercise programme improves arterial function.


Description:

Life expectancies in haemodialysis patients are significantly shorter than the general population due to higher cardiovascular disease risk. This is mediated by higher prevalence of cardiovascular risk factors associated with chronic kidney disease and the haemodialysis procedure. Consequently ageing of the arterial system is accelerated in this condition leading to higher prevalence of arterial plaques and increased arterial stiffness.

Higher physical activity and fitness are associated with lower cardiovascular disease and all-cause mortality in haemodialysis patients and the general population. Moreover, physical inactivity is associated with increased arterial stiffness and plaques which narrow heart arteries. Worryingly the haemodialysis population is on average highly inactive with low fitness.

Current research demonstrates that exercise which improves fitness improves arterial health. Increased bloodflow during exercise stimulates the release of nitric oxide causing arteries to dilate. Regular exercise is believed to lead to beneficial remodelling of arteries and lower arterial stiffness. Exercise is reported to improve arterial function across a range of conditions. However published research regarding the possible benefits of long term aerobic exercise on arterial health in this population is conflicting. Limitations in study design, moderately high participant dropout rates and low statistical power hamper a definitive conclusion. Importantly a gold standard measure of arterial function has not been used in previously published studies.

There is ample evidence that exercise programmes in people on dialysis improve fitness, physical function, and quality of life. It is also clear that a state of higher physical activity and fitness is associated with better arterial function in the general population. It would be advantageous for reasons of health counselling to determine whether the process of improving physical fitness and activity levels may also improve arterial health in haemodialysis patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date February 2014
Est. primary completion date July 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Stage 5 CKD patients (GFR <15 mL/min) receiving maintenance haemodialysis therapy

- Male or female

- Aged >18 years

- Written informed consent

Exclusion Criteria:

- Pregnancy

- Unstable cardiovascular conditions

- Recent cerebrovascular event

- Excess inter-dialytic weight gain

- Use of corticosteroids, anabolic therapies,

- Co-morbid catabolic conditions

- Serum potassium regularly >6mmol/L

- Recent pulmonary thromboembolism

- Psychiatric illness including anxiety, mood and untreated eating disorders

- Infection or course of antibiotics within one month of study period.

- Dementia or severe cognitive impairment.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Other:
Intradialytic aerobic exercise
Participants in the intervention group will undertake moderate intensity aerobic exercise. Exercise modality will be recumbent cycling during the first two hours of haemodialysis sessions. Exercise prescription is set using a graded exercise test and anchored to a perceived level of exertion using the BORG scale. Training stimulus is maintained by the participant by increasing the cycling resistance when perceived exertion drops by one point at the current resistance level. Adherence and training volume is recorded during the intervention period.
Progressive Muscle relaxation
This is a sequence of stretching and relaxation of the major muscle groups of the body. Participants are initially given detailed information regarding the technique and then provided with a recorded version which they listen to for 30-40 minutes during dialysis sessions. Participants in this group are offered the exercise programme at the end of three months.

Locations

Country Name City State
United Kingdom Monklands Hospital Airdrie

Sponsors (2)

Lead Sponsor Collaborator
Queen Margaret University British Kidney Patients Association

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Brachial artery flow mediated dilatation Brachial artery diameter is measured using vascular ultrasound. A cuff similar to that used for blood pressure is then inflated around the forearm for 5 minutes. Following cuff release vascular ultrasound is used to measure arterial dilation in response to reactive hyperaemia. Relative change in diameter provides a measure of endothelial function. Images are recorded over a period of 4-5 minutes post cuff release. Baseline and 12 week follow-up No
Secondary Aortic pulse wave velocity Aortic pulse wave velocity is measured using a Vicorder (Skidmore Medical, Bristol UK). Briefly the Vicorder measures the time taken for a pulse wave to travel between a pressure cuff located on the carotid artery and another at the site of the femoral artery. The calculated velocity of the pulse wave is a measure of central arterial stiffness. Baseline and three month follow-up No
Secondary Maximal aerobic power Peak aerobic power is assessed using a graded exercise test with respiratory gas analysis. An Astrand protocol will be used with cycle ergometry. Participants continue until volitional exhaustion or the test is terminated by the investigator. An oxygen uptake figure in ml/kg/min is a measure of peak aerobic power (VO2peak) Baseline and three months No
Secondary Timed up-and-go The time taken to stand up from a chair, walk three metres and return is recorded. This is a functional measure of mobility with a threshold time related to falls and fractures. Baseline and three month follow-up No
Secondary Sit-to-stand 5 The time taken to stand up from a chair five times without using upper limb assistance is recorded. This is a surrogate measure of lower limb power with a threshold that is related to balance and risk of falls. Baseline and 3 month follow-up No
Secondary Non exercise questionnaire A non-exercise questionnaire utilising anthropometry, gender and self reported physical activity will be used to estimate aerobic fitness. This method carries minimal burden compared to physical performance tests and is a useful screening tool for health counselling. Baseline and 3 month follow-up No
Secondary Physical activity Physical activity over a seven day period will be measured using an Actigraph accelerometer. The monitor measures body movement as activity counts which may be categorised according to level of intensity using established cut-points. Baseline and 3 month follow-up No
Secondary Kidney Disease Quality of Life Short Form (KDQOL) The KDQOL is a self-administered questionnaire designed to measure generic health related quality life as well as condition specific items. Higher scores indicate better quality of life. Baseline and 3 month follow-up No
Secondary Duke Activity Status Index This self administered 12 item questionnaire provides a self reported measure of physical capacity. Higher scores indicate higher fitness and ability to perform activities of daily living. Baseline and 3 months No
Secondary Leicester Uraemic Symptom Scale (LUSS) The LUSS provides a measure of condition related symptom burden. it records the number of symptoms, frequency and their level of intrusiveness. Baseline and 3 month follow-up No
See also
  Status Clinical Trial Phase
Terminated NCT03539861 - Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients N/A
Recruiting NCT03311321 - Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients N/A
Completed NCT05630729 - Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management N/A
Withdrawn NCT03998917 - Pathophysiological Characterization of the Neuromuscular Function of a Population With Multiple Comorbidities Suffering From Chronic Renal Failure in Pre-dialysis.
Recruiting NCT05489120 - Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD) N/A
Completed NCT04207203 - Healthy Diet Rich in Potassium to Chronic Kidney Disease With Sodium Zirconium Cyclosilicate: A Feasibility Study N/A
Not yet recruiting NCT04608422 - Bioeletric Stimulation in Patients With Chronic Kidney Failure N/A
Completed NCT03868371 - Acute Changes in the Mineral Metabolism After a High Phosphorous Containing Meal in Dialysis Patients N/A
Active, not recruiting NCT05225454 - The Life Style Patterns and the Development Trend of Chronic Diseases in Healthy and Sub-healthy Groups Were Analyzed by Using Data-mining Techniques
Completed NCT03459807 - Blood Pressure Lowering in Dialysis (BOLD) Trial Phase 2
Not yet recruiting NCT03005847 - The Effect of Fermented Papaya Preparation on Patients With Chronic Kidney Disease Under Dialysis Receiving Intravenous Iron N/A
Recruiting NCT05726526 - CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients N/A
Recruiting NCT04330807 - Physiopathology of Neuromuscular Function Related to Fatigue in Chronic Renal Disease N/A
Active, not recruiting NCT02858778 - Timing of Acute Palliative Care Consultation in Critically Ill Patients N/A
Active, not recruiting NCT04034966 - Utility of Telemedicine in the Follow-Up of Patients in Peritoneal Dialysis N/A
Completed NCT04012957 - Desidustat in the Treatment of Anemia in CKD Phase 3
Terminated NCT02039167 - Left Atrial Appendage Occlusion vs. Usual Care in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease N/A
Completed NCT01764854 - Pharmacodynamic Study of AZD1722 in End-stage Renal Disease Patients on Hemodialysis Phase 2
Active, not recruiting NCT06037265 - PR-0164 First in Human Clinical Trial of the PAVmed PortIO Intraosseous Infusion System N/A
Active, not recruiting NCT05350098 - Efficacy of Plant-protein Diets in Patients With Chronic Kidney Disease N/A